Strong Organic Revenue Growth
Ambu delivered a strong organic revenue growth of 13.1% for the year and 15.4% in the endoscopy business, underscoring the momentum in transitioning to single-use endoscopes.
Endoscopy Solutions Expansion
Ambu saw an organic revenue growth of 11.4% in respiratory and launched a new video laryngoscope solution, SureSight, contributing to the growth in this segment.
Investment in Commercial Resources
Ambu continued to invest in commercial resources to sustain growth, reflecting a focus on long-term strategic expansion.
Positive Cash Flow
Ambu ended the year with a positive cash flow of DKK 407 million, showcasing strong financial management.
Launch of ZOOM AHEAD Strategy
Ambu launched its ZOOM AHEAD strategy aiming for global endoscopy leadership, building on the successful ZOOM IN strategy.